These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 23941729)
41. Metabolism of vitamin D3 by cytochromes P450. Sakaki T; Kagawa N; Yamamoto K; Inouye K Front Biosci; 2005 Jan; 10():119-34. PubMed ID: 15574355 [TBL] [Abstract][Full Text] [Related]
42. Vitamin D metabolism in the chronic streptozotocin-induced diabetic rat. Hough S; Fausto A; Sonn Y; Dong Jo OK; Birge SJ; Avioli LV Endocrinology; 1983 Aug; 113(2):790-6. PubMed ID: 6307655 [TBL] [Abstract][Full Text] [Related]
43. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue. Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049 [TBL] [Abstract][Full Text] [Related]
44. Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D. Flanagan JN; Young MV; Persons KS; Wang L; Mathieu JS; Whitlatch LW; Holick MF; Chen TC Anticancer Res; 2006; 26(4A):2567-72. PubMed ID: 16886665 [TBL] [Abstract][Full Text] [Related]
45. 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Takeyama K; Kitanaka S; Sato T; Kobori M; Yanagisawa J; Kato S Science; 1997 Sep; 277(5333):1827-30. PubMed ID: 9295274 [TBL] [Abstract][Full Text] [Related]
46. Co-expression of 1α-hydroxylase and vitamin D receptor in human articular chondrocytes. Hansen AK; Figenschau Y; Zubiaurre-Martinez I BMC Musculoskelet Disord; 2017 Nov; 18(1):432. PubMed ID: 29110708 [TBL] [Abstract][Full Text] [Related]
47. Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Kállay E; Bareis P; Bajna E; Kriwanek S; Bonner E; Toyokuni S; Cross HS Food Chem Toxicol; 2002 Aug; 40(8):1191-6. PubMed ID: 12067583 [TBL] [Abstract][Full Text] [Related]
48. Generation of novel genetically modified rats to reveal the molecular mechanisms of vitamin D actions. Nishikawa M; Yasuda K; Takamatsu M; Abe K; Okamoto K; Horibe K; Mano H; Nakagawa K; Tsugawa N; Hirota Y; Horie T; Hinoi E; Okano T; Ikushiro S; Sakaki T Sci Rep; 2020 Mar; 10(1):5677. PubMed ID: 32231239 [TBL] [Abstract][Full Text] [Related]
49. Expression of vitamin D receptor and 25-hydroxyvitamin D3-1{alpha}-hydroxylase in normal and malignant human colon. Matusiak D; Murillo G; Carroll RE; Mehta RG; Benya RV Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2370-6. PubMed ID: 16214919 [TBL] [Abstract][Full Text] [Related]
50. Consequences of vitamin D receptor regulation for the 1,25-dihydroxyvitamin D3-induced 24-hydroxylase activity in osteoblast-like cells: initiation of the C24-oxidation pathway. Staal A; van den Bemd GJ; Birkenhäger JC; Pols HA; van Leeuwen JP Bone; 1997 Mar; 20(3):237-43. PubMed ID: 9071474 [TBL] [Abstract][Full Text] [Related]
51. The Vitamin D endocrine system of the gut--its possible role in colorectal cancer prevention. Cross HS; Bises G; Lechner D; Manhardt T; Kállay E J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):121-8. PubMed ID: 16081282 [TBL] [Abstract][Full Text] [Related]
52. Analysis of the vitamin D system in cutaneous malignancies. Kamradt J; Rafi L; Mitschele T; Meineke V; Gärtner BC; Wolfgang T; Holick MF; Reichrath J Recent Results Cancer Res; 2003; 164():259-69. PubMed ID: 12899528 [TBL] [Abstract][Full Text] [Related]
53. Vitamin D Metabolism Is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease. Jolliffe DA; Stefanidis C; Wang Z; Kermani NZ; Dimitrov V; White JH; McDonough JE; Janssens W; Pfeffer P; Griffiths CJ; Bush A; Guo Y; Christenson S; Adcock IM; Chung KF; Thummel KE; Martineau AR Am J Respir Crit Care Med; 2020 Aug; 202(3):371-382. PubMed ID: 32186892 [No Abstract] [Full Text] [Related]
54. Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro. Li D; Wang X; Wu JL; Quan WQ; Ma L; Yang F; Wu KY; Wan HY PLoS One; 2013; 8(2):e56616. PubMed ID: 23424670 [TBL] [Abstract][Full Text] [Related]
55. Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alpha-hydroxylase activity and regulation of side-chain metabolism. Cross HS; Peterlik M; Reddy GS; Schuster I J Steroid Biochem Mol Biol; 1997 May; 62(1):21-8. PubMed ID: 9366495 [TBL] [Abstract][Full Text] [Related]
56. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue. Smolders J; Schuurman KG; van Strien ME; Melief J; Hendrickx D; Hol EM; van Eden C; Luchetti S; Huitinga I J Neuropathol Exp Neurol; 2013 Feb; 72(2):91-105. PubMed ID: 23334593 [TBL] [Abstract][Full Text] [Related]
57. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Miller GJ; Stapleton GE; Hedlund TE; Moffat KA Clin Cancer Res; 1995 Sep; 1(9):997-1003. PubMed ID: 9816072 [TBL] [Abstract][Full Text] [Related]
58. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5. Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001 [TBL] [Abstract][Full Text] [Related]